Literature DB >> 22923454

Establishing a standard of care for small bowel adenocarcinomas: challenges and lessons learned.

Thorvardur R Halfdanarson1, Axel Grothey.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22923454      PMCID： PMC3448405          DOI： 10.1634/theoncologist.2012-0323

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  18 in total

1.  The American College of Surgeons Commission on Cancer and the American Cancer Society. Adenocarcinoma of the small bowel: review of the National Cancer Data Base, 1985-1995.

Authors:  J R Howe; L H Karnell; H R Menck; C Scott-Conner
Journal:  Cancer       Date:  1999-12-15       Impact factor: 6.860

2.  Bevacizumab-based therapy for advanced small bowel adenocarcinoma.

Authors:  H Tsang; T Yau; P L Khong; R J Epstein
Journal:  Gut       Date:  2008-11       Impact factor: 23.059

3.  Multicenter retrospective study of 132 patients with unresectable small bowel adenocarcinoma treated with chemotherapy.

Authors:  Takahiro Tsushima; Masataka Taguri; Yoshitaka Honma; Hideaki Takahashi; Shinya Ueda; Tomohiro Nishina; Hiroki Kawai; Shunsuke Kato; Mitsukuni Suenaga; Fumio Tamura; Satoshi Morita; Narikazu Boku
Journal:  Oncologist       Date:  2012-05-23

4.  Immunohistochemical investigation of tumorigenic pathways in small intestinal adenocarcinoma: a comparison with colorectal adenocarcinoma.

Authors:  Megan Q Zhang; Zong-Ming E Chen; Hanlin L Wang
Journal:  Mod Pathol       Date:  2006-04       Impact factor: 7.842

5.  Phase II study of 5-fluorouracil, doxorubicin, and mitomycin C for metastatic small bowel adenocarcinoma.

Authors:  Michael K Gibson; Christina A Holcroft; Larry K Kvols; Daniel Haller
Journal:  Oncologist       Date:  2005-02

Review 6.  Pathogenesis and risk factors of small bowel adenocarcinoma: a colorectal cancer sibling?

Authors:  Thierry Delaunoit; Florence Neczyporenko; Paul J Limburg; Charles Erlichman
Journal:  Am J Gastroenterol       Date:  2005-03       Impact factor: 10.864

7.  Small-bowel cancer in Lynch syndrome: is it time for surveillance?

Authors:  Jan J Koornstra; Jan H Kleibeuker; Hans F A Vasen
Journal:  Lancet Oncol       Date:  2008-09       Impact factor: 41.316

8.  Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years.

Authors:  Karl Y Bilimoria; David J Bentrem; Jeffrey D Wayne; Clifford Y Ko; Charles L Bennett; Mark S Talamonti
Journal:  Ann Surg       Date:  2009-01       Impact factor: 12.969

9.  Chemotherapy with 5-fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinoma.

Authors:  Michael J Overman; Scott Kopetz; Sijin Wen; Paulo M Hoff; David Fogelman; Jeffrey Morris; James L Abbruzzese; Jaffer A Ajani; Robert A Wolff
Journal:  Cancer       Date:  2008-10-15       Impact factor: 6.860

10.  Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater.

Authors:  Michael J Overman; Gauri R Varadhachary; Scott Kopetz; Rosni Adinin; E Lin; Jeffrey S Morris; Cathy Eng; James L Abbruzzese; Robert A Wolff
Journal:  J Clin Oncol       Date:  2009-01-21       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.